Evidence map›Paper›PMID 31519952›Full record

ArticleScientific reports2019

Fatty acid transport protein 4 is required for incorporation of saturated ultralong-chain fatty acids into epidermal ceramides and monoacylglycerols.

Meei-Hua Lin, Fong-Fu Hsu, Debra Crumrine, Jason Meyer, Peter M Elias, Jeffrey H Miner

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Ceramides in Skin Health and Disease: An Update.American journal of clinical dermatology · 2021
    Review
  13. Article
  14. Article
  15. Mass Spectrometry-Based Lipidomics: An Overview.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Meei-Hua LinDivision of Nephrology, Washington University School of Medicine, 4523 Clayton Ave., St. Louis, MO, 63110, United States.
Fong-Fu HsuDivision of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Washington University School of Medicine, 4523 Clayton Ave., St. Louis, MO, 63110, United States.
Debra CrumrineDermatology Service, VA Medical Center and Department of Dermatology, University of California-San Francisco, 4150 Clement St., San Francisco, CA, 94121, United States.
Jason MeyerDermatology Service, VA Medical Center and Department of Dermatology, University of California-San Francisco, 4150 Clement St., San Francisco, CA, 94121, United States.
Peter M EliasDermatology Service, VA Medical Center and Department of Dermatology, University of California-San Francisco, 4150 Clement St., San Francisco, CA, 94121, United States.
Jeffrey H MinerDivision of Nephrology, Washington University School of Medicine, 4523 Clayton Ave., St. Louis, MO, 63110, United States. minerj@wustl.edu.ORCID http://orcid.org/0000-0002-1510-8714
San Francisco VA Medical Center · USWashington University in St. Louis · US

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI David W Piston · 2013 to 2026
$27.1M
TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2012 to 2019
$12.0M
UCSF Dermatology Training GrantT32AR007175 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Wilson Liao, Michael David Rosenblum · 1986 to 2026
$6.1M
Pathogenesis and Therapy of Ichthyosis in Disorders of Lipid MetabolismR01AR061106 · NIAMS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MAURO, THEODORA M · 2012 to 2022
$3.3M
Role of FATP4 in Skin DevelopmentR01AR049269 · NIAMS · WASHINGTON UNIVERSITY · PI MINER, JEFFREY H · 2003 to 2012
$2.4M
ANIMAL SUPPORT SPACE FOR NEUROSCIENCEC06RR015502 · NCRR · WASHINGTON UNIVERSITY · PI CICERO, THEODORE J · 2000 to 2000
$2.0M
LIW5T32AR007284 · NIAMS · WASHINGTON UNIVERSITY · PI BOWCOCK, ANNE MARY · 1986 to 2008
$1.2M
NCRR NIH HHS C06 RR015502NIAMS NIH HHS R01 AR049269NIAMS NIH HHS R01 AR061106NIAMS NIH HHS T32 AR007175NIAMS NIH HHS T32 AR007284NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK052574NIDDK NIH HHS P30 DK056341NIGMS NIH HHS P41 GM103422
6 · The paper itself

Abstract

Fatty acid transport protein 4 (FATP4) is an acyl-CoA synthetase that is required for normal permeability barrier in mammalian skin. FATP4 (SLC27A4) mutations cause ichthyosis prematurity syndrome, a nonlethal disorder. In contrast, Fatp4

Indexed as

AnimalsCeramidesFatty AcidsFatty Acid Transport ProteinsKeratinocytesLipidsMiceMice, TransgenicMonoglyceridesSkinCeramidesFatty AcidsFatty Acid Transport ProteinsLipidsMonoglyceridesSlc27a1 protein, mouseSlc27a4 protein, mouse

Identifiers

PMID31519952
PMCPMC6744566
OpenAlexW2972356765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.